Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
3.
Clinics (Sao Paulo) ; 75: e1762, 2020.
Article in English | MEDLINE | ID: mdl-33146350

ABSTRACT

OBJECTIVE: This study aimed to determine the relationship between rs17576 (MMP-9) polymorphism and increased cancer risk in a Brazilian breast cancer cohort. METHODS: This study included 141 women (71 breast cancer patients and 70 controls without breast cancer) who donated 3 mL of their peripheral blood for genomic DNA extraction. This DNA was then genotyped using a real-time polymerase chain reaction. RESULTS: The AG (rs17576) genotype was identified in 26 (18.43%) participants in the case group and in 22 (15.60%) participants in the control group (p=0.274), while the GG genotype was identified in ten (7.09%) participants in the case group and in one (0.70%) participant in the control group (p<0.003 - OR (95% CI) 13.13 (1.73, 593.08). No significant difference in the incidence rates was observed for AG or GG rs17576 genotypes in premenopausal women, p=0.813 and p=0.556, respectively. However, in postmenopausal women, the AG genotype was shown to occur in 14 (22.5%) participants in the case group and in 4 (6.45%) participants in the control (p<0.043), while GG genotype occurred in eight (12.90%) of the individuals in the case group and in none of the individuals in the control group (p<0.006). CONCLUSION: In this study, the MMP-9 rs17576 GG polymorphic variant was shown to be significantly associated with breast cancer risk in premenopausal women, while the AG and GG genotypes were associated with increased cancer risk in postmenopausal women.


Subject(s)
Breast Neoplasms , Matrix Metalloproteinase 9 , Brazil , Breast Neoplasms/genetics , Case-Control Studies , Female , Genetic Predisposition to Disease , Genotype , Humans , Matrix Metalloproteinase 9/genetics , Polymorphism, Single Nucleotide , Risk Factors
4.
Clinics (Sao Paulo) ; 75: e1805, 2020.
Article in English | MEDLINE | ID: mdl-32725074

ABSTRACT

OBJECTIVES: In breast cancer diagnosis, mammography (MMG), ultrasonography (USG) and magnetic resonance imaging (MRI) are the imaging methods most used. There is a scarcity of comparative studies that evaluate the accuracy of these methods in the diagnosis of breast cancer. METHODS: A cross-sectional study was carried out through the review of electronic medical records of 32 female patients who underwent breast imaging examinations at a imaging diagnostic center in Teresina, State of Piauí, Brazil. Patients who had these three imaging methods at the time of the evaluation of the same nodule were included. The nodule must have been classified as suspect by the BI-RADS® system in at least one of the methods. Data from each method were compared with the histopathological examination. Statistical analysis used the calculation of proportions in Excel 2010. RESULTS: MMG showed 56.2%, 87.5%, 81.8%, 66.7% and 71.8% of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy, respectively. USG had 75%, 18.8%, 48%, 42.8% and 46.9% of sensitivity, specificity, PPV, NPV and accuracy, respectively. In turn, MRI had 100%, 50%, 66.7%, 100% and 75% of sensitivity, specificity, PPV, NPV and accuracy, respectively. CONCLUSION: Thus, MRI and MMG were more accurate in evaluating suspicious breast lumps. MRI had a low specificity, mainly to high breast density, while MMG had also sensitivity limited due to high breast density and USG has been proven to be useful in these patients.


Subject(s)
Breast Neoplasms , Ultrasonography, Mammary , Brazil , Breast/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Cross-Sectional Studies , Female , Humans , Magnetic Resonance Imaging , Mammography , Sensitivity and Specificity , Ultrasonography
5.
Clinics (Sao Paulo) ; 75: e1643, 2020.
Article in English | MEDLINE | ID: mdl-32267395

ABSTRACT

OBJECTIVES: Aromatase inhibitors are the first-choice drugs for the treatment of hormone sensitive breast cancer. However, in addition to the scarcity of studies, there are controversies about their effects on vaginal epithelial cell proliferation in rats, especially those in persistent estrus. METHODS: To investigate vaginal epithelial cell proliferation by Ki-67 antigen expression, persistent estrus was induced in 42 randomly selected rats. These rats were randomly divided into 2 groups: group I (control, n=21), which received 0.1 mL of propylene glycol (vehicle) daily, and group II (experimental, n=21), which received 0.5 mg/kg or 0.125 mg/day of anastrozole diluted with 0.1 mL of propylene glycol. RESULTS: Light microscopy showed a higher concentration of cells with brown Ki-67 stained nuclei in the control compared to the experimental group. The mean percentage of Ki-67 stained nuclei per 500 cells in the vaginal epithelium was 68.64±2.64 and 30.46±2.00 [mean±standard error of the mean (SEM)] in the control and experimental groups, respectively (p<0.003). CONCLUSION: This study showed that anastrozole, at the dose and treatment duration selected, significantly decreased cell proliferation in the vaginal mucosa of the rats in persistent estrus.


Subject(s)
Anastrozole/pharmacology , Epithelium/drug effects , Estrus/metabolism , Ki-67 Antigen/metabolism , Vagina/drug effects , Animals , Epithelium/metabolism , Female , Ki-67 Antigen/drug effects , Random Allocation , Rats , Rats, Wistar , Vagina/metabolism
6.
Clinics ; 75: e1805, 2020. tab
Article in English | LILACS | ID: biblio-1133392

ABSTRACT

OBJECTIVES: In breast cancer diagnosis, mammography (MMG), ultrasonography (USG) and magnetic resonance imaging (MRI) are the imaging methods most used. There is a scarcity of comparative studies that evaluate the accuracy of these methods in the diagnosis of breast cancer. METHODS: A cross-sectional study was carried out through the review of electronic medical records of 32 female patients who underwent breast imaging examinations at a imaging diagnostic center in Teresina, State of Piauí, Brazil. Patients who had these three imaging methods at the time of the evaluation of the same nodule were included. The nodule must have been classified as suspect by the BI-RADS® system in at least one of the methods. Data from each method were compared with the histopathological examination. Statistical analysis used the calculation of proportions in Excel 2010. RESULTS: MMG showed 56.2%, 87.5%, 81.8%, 66.7% and 71.8% of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy, respectively. USG had 75%, 18.8%, 48%, 42.8% and 46.9% of sensitivity, specificity, PPV, NPV and accuracy, respectively. In turn, MRI had 100%, 50%, 66.7%, 100% and 75% of sensitivity, specificity, PPV, NPV and accuracy, respectively. CONCLUSION: Thus, MRI and MMG were more accurate in evaluating suspicious breast lumps. MRI had a low specificity, mainly to high breast density, while MMG had also sensitivity limited due to high breast density and USG has been proven to be useful in these patients.


Subject(s)
Humans , Female , Breast Neoplasms/diagnostic imaging , Ultrasonography, Mammary , Brazil , Breast/diagnostic imaging , Magnetic Resonance Imaging , Mammography , Cross-Sectional Studies , Ultrasonography , Sensitivity and Specificity
7.
Clinics ; 75: e1762, 2020. tab
Article in English | LILACS | ID: biblio-1133434

ABSTRACT

OBJECTIVE: This study aimed to determine the relationship between rs17576 (MMP-9) polymorphism and increased cancer risk in a Brazilian breast cancer cohort. METHODS: This study included 141 women (71 breast cancer patients and 70 controls without breast cancer) who donated 3 mL of their peripheral blood for genomic DNA extraction. This DNA was then genotyped using a real-time polymerase chain reaction. RESULTS: The AG (rs17576) genotype was identified in 26 (18.43%) participants in the case group and in 22 (15.60%) participants in the control group (p=0.274), while the GG genotype was identified in ten (7.09%) participants in the case group and in one (0.70%) participant in the control group (p<0.003 - OR (95% CI) 13.13 (1.73, 593.08). No significant difference in the incidence rates was observed for AG or GG rs17576 genotypes in premenopausal women, p=0.813 and p=0.556, respectively. However, in postmenopausal women, the AG genotype was shown to occur in 14 (22.5%) participants in the case group and in 4 (6.45%) participants in the control (p<0.043), while GG genotype occurred in eight (12.90%) of the individuals in the case group and in none of the individuals in the control group (p<0.006). CONCLUSION: In this study, the MMP-9 rs17576 GG polymorphic variant was shown to be significantly associated with breast cancer risk in premenopausal women, while the AG and GG genotypes were associated with increased cancer risk in postmenopausal women.


Subject(s)
Humans , Female , Breast Neoplasms/genetics , Matrix Metalloproteinase 9/genetics , Brazil , Case-Control Studies , Risk Factors , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Genotype
8.
Clinics ; 75: e1643, 2020. tab, graf
Article in English | LILACS | ID: biblio-1089594

ABSTRACT

OBJECTIVES: Aromatase inhibitors are the first-choice drugs for the treatment of hormone sensitive breast cancer. However, in addition to the scarcity of studies, there are controversies about their effects on vaginal epithelial cell proliferation in rats, especially those in persistent estrus. METHODS: To investigate vaginal epithelial cell proliferation by Ki-67 antigen expression, persistent estrus was induced in 42 randomly selected rats. These rats were randomly divided into 2 groups: group I (control, n=21), which received 0.1 mL of propylene glycol (vehicle) daily, and group II (experimental, n=21), which received 0.5 mg/kg or 0.125 mg/day of anastrozole diluted with 0.1 mL of propylene glycol. RESULTS: Light microscopy showed a higher concentration of cells with brown Ki-67 stained nuclei in the control compared to the experimental group. The mean percentage of Ki-67 stained nuclei per 500 cells in the vaginal epithelium was 68.64±2.64 and 30.46±2.00 [mean±standard error of the mean (SEM)] in the control and experimental groups, respectively (p<0.003). CONCLUSION: This study showed that anastrozole, at the dose and treatment duration selected, significantly decreased cell proliferation in the vaginal mucosa of the rats in persistent estrus.


Subject(s)
Animals , Female , Rats , Vagina/drug effects , Estrus/metabolism , Ki-67 Antigen/metabolism , Epithelium/drug effects , Anastrozole/pharmacology , Vagina/metabolism , Random Allocation , Rats, Wistar , Ki-67 Antigen/drug effects , Epithelium/metabolism
9.
Oncotarget ; 10(64): 6879-6884, 2019 Dec 03.
Article in English | MEDLINE | ID: mdl-31839881

ABSTRACT

BACKGROUND: Matrix metalloproteinases (MMPs) 2 and 9 may play an important role in cell proliferation and dissemination of cancer. However, few studies have compared the expression of these proteins between breast cancer and fibroadenoma. MATERIAL AND METHODS: A randomized, double-blind study was carried out in 66 premenopausal women, aged 20-49 years, who had been diagnosed with fibroadenoma or breast cancer. The patients were divided into two groups: Group A, control (fibroadenoma, n=36) and Group B, study (cancer, n=30). Immunohistochemical analysis was performed using tissue samples of fibroadenoma and breast cancer to assess MMP-2 and MMP-9 antigen expression. Cells were considered positive if exhibiting brown cytoplasmic staining. Fisher's exact test was used to compare the percentage of cases with cells expressing MMP-2 and MMP-9 in control and study groups (p < 0.05). RESULTS: Light microscopy showed a higher concentration of cells with positive cytoplasmic staining for MMP-2 and MMP-9 expression in breast cancer than in fibroadenoma. The percentage of cases with cells expressing MMP-2 in the control and study groups was 41.67% and 86.11%, respectively (p < 0.0009), whereas the percentage of cases with cells expressing MMP-9 in groups A and B was 66.67% and 93.33%, respectively (p<0.0138). MMP-2 and MMP-9 positive expression was significantly higher in moderately differentiated tumors compared to well and poorly differentiated tumors, p <0.005 and p<0.001, respectively. CONCLUSIONS: The current study shows that MMP-2 and MMP-9 protein expression was significantly higher in the breast cancer than in the fibroadenoma and also in moderately differentiated breast cancer.

10.
BMC Cancer ; 18(1): 978, 2018 Oct 16.
Article in English | MEDLINE | ID: mdl-30326852

ABSTRACT

BACKGROUND: Sarcomas account for less than 1% of primary breast cancers, and breast angiosarcomas are responsible for only 0.05% of all breast malignancies. The male breast has the same potential for malignant transformation as the female breast. However, due to anatomical differences in the breast and the low incidence of angiosarcoma, it is difficult to determine how male breasts can be affected by this type of tumor. CASE PRESENTATION: A 36-year-old male patient was admitted to the hospital with a palpable lump in his right breast. Lymphadenopathy was negative. Ultrasonography showed a hypoechoic mass with partially defined contours, measuring 4.0 × 3.0 cm, with muscle infiltration. Histological examination revealed a malignant tumor. Radical mastectomy was then performed with clear surgical margins. The patient began chemotherapy with paclitaxel. Following the second cycle of chemotherapy, he presented with headache and seizures due to a frontal lobe metastasis. Twenty days after the onset of neurological symptoms, the patient died. CONCLUSIONS: Primary angiosarcomas of the male breast are extremely rare. This is the sixth case published in the literature. It is in agreement with other studies in the literature concerning clinical presentation and poor prognosis. Treatment consists in surgical removal of the tumor with clear margins and without axillary lymphadenectomy.


Subject(s)
Brain Neoplasms/secondary , Breast Neoplasms, Male , Hemangiosarcoma , Paclitaxel/therapeutic use , Adult , Breast Neoplasms, Male/pathology , Breast Neoplasms, Male/therapy , Chemotherapy, Adjuvant , Hemangiosarcoma/pathology , Hemangiosarcoma/therapy , Humans , Male
11.
Rev. enferm. UFPE on line ; 12(9): 2269-2275, set. 2018. ilus, tab
Article in Portuguese | BDENF - Nursing | ID: biblio-995663

ABSTRACT

Objetivo: avaliar os cuidados e a satisfação de puérperas assistidas por enfermeiros obstetras em um Centro de Parto Normal. Método: estudo quantitativo, descritivo e exploratório, realizado em uma maternidade pública de referência com 25 puérperas. Os dados foram coletados mediante a adaptação do Questionário de Experiência e Satisfação com o Parto (QEPS) e analisados a partir de estatística descritiva. Resultados: 100% das parturientes destacaram os cuidados para resguardar sua intimidade, o ensinamento de botar força para facilitar a expulsão do bebê e a importância do acompanhante no transcorrer do parto como muito importantes; 91% relataram que sempre receberam informação a respeito do processo parturitivo; 95,7% enfatizaram a importância de estratégias não farmacológicas para acelerar o parto e diminuir a dor e 95,7% mostraram-se satisfeitas com os cuidados prestados pelo enfermeiro obstetra e a equipe de Enfermagem durante o trabalho de parto. Conclusão: a assistência do enfermeiro obstetra foi bastante aceita pelas parturientes, porém, ainda precisa de apoio e acreditação por parte dos demais profissionais da saúde obstétrica.(AU)


Subject(s)
Humans , Female , Pregnancy , Labor, Obstetric , Maternal and Child Health , Patient Satisfaction , Humanizing Delivery , Postpartum Period , Natural Childbirth , Nurse Midwives , Obstetric Nursing , Health Education , Epidemiology, Descriptive , Personal Autonomy , Hospitals, Maternity
SELECTION OF CITATIONS
SEARCH DETAIL
...